Literature DB >> 2295691

Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.

Y L Marcel1, R McPherson, M Hogue, H Czarnecka, Z Zawadzki, P K Weech, M E Whitlock, A R Tall, R W Milne.   

Abstract

A MAb (TP-2) directed against human cholesteryl ester transfer protein (CETP) has been applied to the development of a competitive solid-phase RIA. Experiments with immobilized CETP have shown that upon incubation with plasma or HDL in the presence of Tween (0.05%) apo A-I (but not apo A-II) binds to CETP while TP-2 binding to CETP is concomitantly decreased. With high detergent concentration (0.5% Triton), the interference is eliminated and a specific RIA in which all plasma CETP fractions have the same affinity can be obtained. Plasma levels of CETP, apo A-I, lipids, and lipoproteins were measured in 50 normolipemic, healthy subjects of both sexes. CETP levels varied nearly fourfold with a mean value of 1.7 micrograms/ml. CETP was positively correlated only with apo A-I (r = 0.38) and HDL-triglyceride (r = 0.39). In 29 other normolipemic subjects, where several apolipoproteins were also measured, significant correlations of CETP with apo A-I (0.41), apo E (0.43), and HDL-cholesterol (0.41) were observed, but there was no significant relationship between CETP and either apo A-II, B, or D. In other experiments CETP was shown to be present mostly in HDL3 and VHDL, to display exclusively an alpha 2-electrophoretic migration, and to occur within discrete particles ranging in size from 129 to 154 kD. In conclusion, the association of CETP with apo A-I-containing lipoproteins probably explains the correlation between CETP and apo A-I levels. The relationship between CETP and apo E suggests either a common metabolism or a specific cooperative role in cholesterol ester transport for these proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295691      PMCID: PMC296380          DOI: 10.1172/JCI114397

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles.

Authors:  N M Pattnaik; D B Zilversmit
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

3.  Characterization of monoclonal antibodies against human low density lipoprotein.

Authors:  R W Milne; R Theolis; R B Verdery; Y L Marcel
Journal:  Arteriosclerosis       Date:  1983 Jan-Feb

4.  Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against low density lipoproteins.

Authors:  Y L Marcel; M Hogue; R Theolis; R W Milne
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

5.  The separation of apolipoprotein D from cholesteryl ester transfer protein.

Authors:  R E Morton; D B Zilversmit
Journal:  Biochim Biophys Acta       Date:  1981-01-26

6.  Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein.

Authors:  A R Tall; E Abreu; J Shuman
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

7.  Transfer of cholesterol esters between human high density lipoproteins and triglyceride-rich lipoproteins controlled by a plasma protein factor.

Authors:  Y L Marcel; C Vezina; B Teng; A Sniderman
Journal:  Atherosclerosis       Date:  1980-02       Impact factor: 5.162

8.  Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.

Authors:  N R Phillips; R J Havel; J P Kane
Journal:  Am J Epidemiol       Date:  1982-08       Impact factor: 4.897

9.  Characterization of monoclonal antibodies against human apolipoprotein E.

Authors:  R W Milne; P Douste-Blazy; Y L Marcel; L Retegui
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

10.  Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.

Authors:  R W Mahley; D Y Hui; T L Innerarity; K H Weisgraber
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  38 in total

1.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.

Authors:  T Hayek; T Chajek-Shaul; A Walsh; L B Agellon; P Moulin; A R Tall; J L Breslow
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Marine lipids normalize cholesteryl ester transfer in IDDM.

Authors:  J D Bagdade; M Ritter; P V Subbaiah
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.

Authors:  J C Cohen; Z Wang; S M Grundy; M R Stoesz; R Guerra
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

5.  Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.

Authors:  J Lie; R de Crom; M Jauhiainen; T van Gent; R van Haperen; L Scheek; H Jansen; C Ehnholm; A van Tol
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 6.  Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

Authors:  Jia-Ming Xu; Guo-Ping Shi
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

7.  Function of cholesteryl ester transfer protein in reverse cholesterol transport.

Authors:  R McPherson
Journal:  CMAJ       Date:  1993-06-15       Impact factor: 8.262

8.  Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.

Authors:  L Masucci-Magoulas; P Moulin; X C Jiang; H Richardson; A Walsh; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences.

Authors:  X C Jiang; L B Agellon; A Walsh; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness.

Authors:  B Föger; G Luef; A Ritsch; C Schmidauer; A Doblinger; M Lechleitner; F Aichner; J R Patsch
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.